Dermatology and Hyperhidrosis
Dryox Health S.L. is focused on clinical research in severe primary hand hyperhidrosis, with attention to excessive sweating affecting the palms and its impact on daily function and comfort.
- Primary hand hyperhidrosis
- Severe sweating disorders
- Palmar hyperhidrosis
The sponsor’s research activity is centered on treatment options for a localized dermatological condition that requires targeted symptom control.
Topical Therapeutics
The company’s clinical interest includes topical treatment approaches designed for direct application to affected skin areas, reflecting a focus on locally acting therapies.
- Topical gel formulations
- Local symptom management
- Skin-applied therapies
This area highlights research into cutaneous interventions intended to address sweating at the site of symptoms.
Anticholinergic Treatment Interest
Dryox Health S.L. is involved in research on anticholinergic therapy, with particular relevance to agents used in managing excessive sweating through peripheral action.
- Tiotropium bromide
- Sweat gland inhibition
- Peripheral anticholinergic activity
The therapeutic focus is on pharmacological control of palmar sweating using a locally delivered compound.
Symptom Burden in Hand Conditions
Its research landscape also touches on the functional burden of hand hyperhidrosis, a condition that can interfere with manual tasks, social interaction, and everyday activities.
- Functional impairment
- Quality-of-life impact
- Hand-related discomfort
Clinical interest remains concentrated on improving management of a localized condition within dermatologic care.
